Retrospective financial analysis of wellness center from an independent community pharmacy perspective

Journal of the American Pharmacists Association

Volumn 46, Issue 4, 2006, Pages 447-452

  Kent, Kelly ^a   McDonough, Randal P ^b   Dinges, Beth ^c   Doucette, William R ^d  

^a Liberty Pharmacy   (United States)

^b Towncrest Pharmacy   (United States)

^c SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Community and ambulatory pharmacy; Disease management; Pharmacoeconomics; Pharmacy management; Wellness

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN;

BLOOD PRESSURE MONITORING; BODY FAT; BONE DENSITY; CONTROLLED STUDY; FINANCIAL MANAGEMENT; GLUCOSE BLOOD LEVEL; HEALTH CENTER; HEALTH SERVICE; HUMAN; MEDICAL RECORD; PHARMACIST; PHARMACY; REVIEW; WELLBEING; ARTICLE; COST; ECONOMICS; HEALTH PROMOTION; MASS SCREENING; ORGANIZATION AND MANAGEMENT; RETROSPECTIVE STUDY;

COMMUNITY PHARMACY SERVICES; COSTS AND COST ANALYSIS; FITNESS CENTERS; HEALTH PROMOTION; HUMANS; MASS SCREENING; RETROSPECTIVE STUDIES;

EID: 33748541085     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/154434506778073646     Document Type: Article

References (34)

1. Dhoot A, Rutter PM. The provision of diagnostic and screening services by community pharmacies. Int J Pharm Prac. 2002;10(suppl):R51.
2. Ernst ME, Doucette WR, Dedhiya SD, et al. Use of a point-of-service health status assessment by community pharmacists to identify and resolve drug-related problems in patients with musculoskeletal disorders. Pharmacotherapy. 2001;21:988-97.
3. Kassam R, Farris KB, Burback L, et al. Pharmaceutical care research and education project: pharmacists' interventions. J Am Pharm Assoc. 2001;41:401-10.
4. Cipolle RJ, Strand LM, Morley PC. Outcomes of pharmaceutical care practice. In: Pharmaceutical care practice. New York: McGraw-Hill; 1998.
5. Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother. 1997;31:713-9.
6. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project ImPACT: Hyperlipidemia. J Am Pharm Assoc. 2000;40:157-65.
7. Cranor CW, Christensen DB. The Asheville Project: factors associated with outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:160-72.
8. Herborg H, Sondergaard B, Froekjaer B, et al. Improving drug therapy for patients with asthma part 1: patient outcomes. J Am Pharm Assoc. 2001;41:339-50.
9. Cardina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2001;21:1196-203.
10. Carter BL, Barnette DJ, Chrischilles E, et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy. 1997;17:1274-85.
11. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc. 1996;NS36:443-51.
12. Christensen DB, Holmes G, Fassatt WE, et al. Influence of a financial incentive on cognitive services: CARE Project design/implementation. J Am Pharm Assoc. 1999;39:629-39.
13. Smith DH, Fassett WE, Christensen DB. Washington State CARE project: downstream cost changes associated with the provision of cognitive services by pharmacists. J Am Pharm Assoc. 1999;39:650-7.
14. Simpson SH, Johnson JA, Tsuyuki RT. Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists. Pharmacotherapy. 2001;21:627-35.
15. Kennedy DT, Giles JT, Chang ZG, et al. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc. 2002;42:51-6.
16. Knowlton CH, Thomas OV, Williamson A, et al. Establishing community-based anticoagulation education and monitoring programs. J Am Pharm Assoc. 1999;39:368-74.
17. McCurdy M. Oral anticoagulation monitoring in a community pharmacy. Am Pharm. 1993;10:61-70.
18. Elliott ME, Meek PD, Kanous NL, et al. Osteoporosis screening by community pharmacists: use of national osteoporosis foundation resources. J Am Pharm Assoc. 2002;42:101-10.
19. Wilson JB, Osterhaus MC, Farris KB, et al. Financial analysis of cardiovascular wellness program provided to self-insured company from pharmaceutical care provider's perspective. J Am Pharm Assoc. 2005;45:588-92.
20. McDonough RP, Doucette WR, Kumbera P, Klepser DG. An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis. Value Health. 2005;8:24-31.
21. Swain JH, Macklin R. Individualized diabetes care in a rural community pharmacy. J Am Pharm Assoc. 2001;41:458-61.
22. Berringer R, Shibely MC, Cary CC, et al. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc. 1999;39:791-7.
23. Ernst ME, Iyer S, Doucette WR. Drug-related problems and quality-of-life in arthritis and low back pain sufferers. Value Health. 2003;6:51-8.
24. Farris KB, Urmie JM, Fang G, et al. population-based medication reviews: a descriptive analysis of the medication issues identified in a Medicare not-for-profit prescription discount program. Ann Pharmacother. 2004;38:1823-9.
25. Kotecki JE, Elanjian SI, Torabi MR. Health promotion beliefs and practices among pharmacists. J Am Pharm Assoc. 2000;40:773-9.
26. Madejski RM, Madejski TJ. Cholesterol screening in a community pharmacy. J Am Pharm Assoc. 1996;NS36:243-8.
27. Cote I, Gregoire JP, Moisan J, et al. A pharmacy-based health promotion programme in hypertension. Pharmacoeconomics. 2003;21:415-28.
28. Carter BL, Chrischilles EA, Scholz E, et al. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program. J Am Pharm Assoc. 2003;43:24-33.
29. Chrischilles EA, Carter BL, Lund BC, et al. Evaluation of the Iowa Medicaid Pharmaceutical Case Management program. J Am Pharm Assoc. 2004;44:337-49.
30. Gronroos C. Return on service and relationship. In: Gronroos C. Service management and marketing, 2nd ed. New York: John Wiley and Sons; 2000:125-62.
31. Cerulli J, Zeolla MM. Impact and feasibility of a community pharmacy bone density screening and education program. J Am Pharm Assoc. 2004;44:161-7.
32. Goode JV, Swiger K, Bluml BM. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis. J Am Pharm Assoc. 2004;44:152-60.
33. Tice B, Phillips CR. Implementation and evaluation of a lipid-screening program in a large chain pharmacy. J Am Pharm Assoc. 2002;42:413-9.
34. State and county quick facts. U.S. Census Bureau Web site. Accessed at www.census.gov, March 9, 2005.